✦ LIBER ✦

COMBINED TREATMENT WITH LHRH AGONIST AND PURE ANTIANDROGEN IN ADVANCED CARCINOMA OF PROSTATE

✍ Scribed by Labrie, Fernand; Belanger, Alain; Dupont, Andre; Emond, Jean; Lacoursiere, Yves; Monfette, Gerard

Book ID: 122453357
Publisher: The Lancet
Year: 1984
Tongue: English
Weight: 150 KB
Volume: 324
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(84)91521-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Androgen levels in prostatic tissue of p

Androgen levels in prostatic tissue of patients with carcinoma of the prostate treated with the combined therapy using an LHRH agonist and a pure antiandrogen

✍ Bélanger, A.; Labrie, F.; Dupont, A. 📂 Article 📅 1986 🏛 Elsevier Science ⚖ 158 KB

New hormonal treatment in cancer of the

New hormonal treatment in cancer of the prostate: Combined administration of an LHRH agonist and an antiandrogen

✍ F. Labrie; A. Dupont; A. Belanger; F.A. Lefebvre; L. Cusan; G. Monfette; J.-G. L 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 987 KB

Luteinizing hormone-releasing hormone (L

Luteinizing hormone-releasing hormone (LHRH) agonists for treatment of advanced prostatic carcinoma

✍ Gerald W. Chodak 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 393 KB

LOSS OF LUTEINIZING HORMONE BIOACTIVITY

LOSS OF LUTEINIZING HORMONE BIOACTIVITY IN PATIENTS WITH PROSTATIC CANCER TREATED WITH AN LHRH AGONIST AND A PURE ANTIANDROGEN

✍ R. ST-ARNAUD; R. LACHANCE; SUSAN J. KELLY; BELANGER. A. DUPONT; F. LABRIE 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 646 KB

THERAPEUTIC POTENTIAL OF THE LHRH AGONIS

THERAPEUTIC POTENTIAL OF THE LHRH AGONIST, ICI 118630, IN THE TREATMENT OF ADVANCED PROSTATIC CARCINOMA

✍ Walker, K.J.; Turkes, A.O.; Nicholson, R.I.; Turkes, A.; Griffiths, K.; Robinson 📂 Article 📅 1983 🏛 The Lancet 🌐 English ⚖ 349 KB

Simultaneous antiandrogen withdrawal and

Simultaneous antiandrogen withdrawal and treatment with ketoconazole and hydrocortisone in patients with advanced prostate carcinoma

✍ Eric J. Small; Ari Baron; Robert Bok 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

drawal and simultaneous ketoconazole as a means of inhibiting adrenal steroid production. Prostate specific antigen (PSA) response was defined as a ú 50% fall in PSA from baseline that was maintained for at least 8 weeks. ## RESULTS. Ten patients had established metastatic disease, 2 had high PSA